PT 141 dosage explained: the FDA-approved 1.75 mg bremelanotide injection, how reconstitution changes the math, off-label male doses, and safety warnings.
PT-141 dosage depends on which version of the drug you mean. The FDA-approved product, bremelanotide (brand name Vyleesi), is dosed at 1.75 mg injected under the skin, no more than once every 24 hours. Off-label and research amounts discussed online usually fall between 1 mg and 2 mg per dose, and those figures come from small studies and gray-market vials rather than an approved label.
What PT-141 Is and How It Works
PT-141 is the research name for bremelanotide, a synthetic peptide that activates melanocortin receptors in the brain. It does not work like Viagra or Cialis, which affect blood flow. PT-141 works through the central nervous system and is associated with increased sexual desire in some users.
The FDA approved bremelanotide in 2019 as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women. It is a prescription injectable, not a pill, and it is not approved for men, for bodybuilding, or for general sexual enhancement.
The FDA-Approved PT-141 Dosage
The label is unusually specific for a peptide product. The approved pt-141 dosage for women with HSDD is a single 1.75 mg subcutaneous injection into the thigh or abdomen at least 45 minutes before anticipated sexual activity.
- Maximum frequency: one dose per 24 hours.
- Monthly limit: no more than 8 doses per month.
- Timing: about 45 minutes before sex.
- Missed dose: skip it and wait for the next opportunity; do not double up.
Clinical trials tested higher amounts, and those doses produced more nausea, vomiting, and short-term blood pressure increases without better results. More is not better with this drug.
Off-Label Dosing and Use in Men
PT-141 has been studied as a treatment for erectile dysfunction, and it showed measurable effects in some trials, but the FDA never approved it for that purpose. Most published reports of pt-141 dosage male use describe 1 mg to 2 mg per injection, often starting near 1 mg to check tolerance.
There is no official 10 mg dose for men. A 10 mg figure refers to the size of a research vial, not a single injection, and a vial like that is meant to be reconstituted and divided into many smaller doses. Injecting an entire 10 mg vial would deliver roughly six times the FDA-approved amount.
The same logic applies to bodybuilding use. PT-141 is not an anabolic compound, it does not build muscle, and stacking it with steroids or other peptides adds risk without any documented payoff.
Reconstitution, Milliliters, and Concentration Math
Most non-pharmacy PT-141 is sold as a lyophilized powder that must be mixed with bacteriostatic water before use. That single step is why questions about pt-141 reconstitution and dosage generate so much confusion, because the resulting strength depends entirely on how much liquid is added.
Concentration equals total peptide divided by total diluent. A 10 mg vial mixed with 2 mL of water yields 5 mg/mL, so a 1 mg dose equals 0.2 mL. The same vial mixed with 1 mL yields 10 mg/mL, so 1 mg equals 0.1 mL. On a U-100 insulin syringe, 0.2 mL reads as 20 units and 0.1 mL reads as 10 units.
So what does pt-141 dosage in ml look like in practice? It is never a fixed number. The milliliter amount changes with the vial size and the volume of water used, which is exactly why pharmacy-made autoinjectors exist. Small math errors with a reconstituted vial can multiply a dose several times over.
PT-141 Dosage Comparison Chart
| Setting | Typical dose | Route | Frequency | Evidence behind it |
|---|---|---|---|---|
| FDA-approved (Vyleesi, premenopausal women with HSDD) | 1.75 mg | Subcutaneous | Max 1 per 24 hours; 8 per month | Large randomized trials and an FDA label |
| Off-label use in men | 1–2 mg | Subcutaneous | Not established | Small studies and case reports |
| Research or gray-market vials | Varies by mixing | Subcutaneous | Not established | No standardized data; depends on user math |
A pt-141 peptide dosage chart is only as trustworthy as its source. A table built from the FDA label carries real weight; a table copied from a forum post does not.
Side Effects and Safety Considerations
- Nausea — the most commonly reported side effect in trials, and the main reason people stop using it.
- Headache, flushing, and injection-site reactions.
- Temporary increases in blood pressure and heart rate.
- Focal hyperpigmentation — dark patches on the skin, gums, or nails after repeated use.
PT-141 is not recommended for people with uncontrolled high blood pressure or known cardiovascular disease. Alcohol can worsen nausea, and combining PT-141 with blood pressure medication, antidepressants, or other peptides should only happen under medical supervision.
PT-141 is a prescription drug in the United States, which means research-chemical listings come with no purity guarantee, no accurate dosing information, and no clinical oversight. Anyone considering it should talk with a healthcare professional first.
The Bottom Line on PT-141 Dosage
PT-141 is FDA-approved only as Vyleesi for premenopausal women with HSDD. The approved dose is 1.75 mg under the skin, once per 24 hours and no more than eight times a month. There is no FDA-approved PT-141 dose for men, for bodybuilding, or for general sexual enhancement.
Frequently Asked Questions
What is the standard PT-141 dosage?
The FDA-approved dose of PT-141 (bremelanotide, sold as Vyleesi) is 1.75 mg injected under the skin at least 45 minutes before anticipated sexual activity, with no more than one dose every 24 hours and no more than eight doses per month. Higher doses were tested in trials and caused more nausea without better results.
How long does PT-141 take to work?
PT-141 is typically injected about 45 minutes before sexual activity, and its effects can last for several hours. Onset and response vary between people, and the drug does not work for everyone. Severe nausea, vomiting, or a spike in blood pressure are reasons to contact a healthcare provider.
Is PT-141 safe for men?
PT-141 is not FDA-approved for men. Some studies have explored it for erectile dysfunction with mixed results, and reported side effects include nausea, flushing, and headache. Men who are interested in PT-141 should discuss it with a physician instead of self-dosing from a research vial.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.